A case report of advanced pancreatic neuroendocrine carcinoma with Ki67 80%, CPS 0, and pMMR achieving durable complete response for over 7 years after combination immunotherapy. The gene discussed is MKI67; the disease is pancreatic endocrine carcinoma.